AI Rebuilds $50B Pharma Giant's Thinking, Plan Could Help Every Data-Driven Firm GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms accelerate hypothesis generation, imaging analysis and drug discovery workflows, offering CIOs a blueprint for enterprise-scale AI transformation in regulated industries.
Déjà Vu: Is Mythos in Hands of Bad Actors Akin to Cobalt Strike, Brute Ratel Abuse? Anthropic's Claude Mythos and similarly powerful artificial intelligence tools pose elevated cyber risk to the healthcare sector, warns a new report. Addressing the onslaught of newly discovered bugs will require healthcare organizations to evolve their vulnerability mindsets.
Musk's Claims Against Altman and Microsoft Dismissed After Less Than Two Hours A federal jury took less than two hours to dismiss Elon Musk's lawsuit against OpenAI and Sam Altman, finding his claims were filed outside the statute of limitations. The verdict clears the path for OpenAI's planned IPO at a valuation nearing $1 trillion.
AI Rebuilds $50B Pharma Giant's Thinking, Plan Could Help Every Data-Driven Firm GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms accelerate hypothesis generation, imaging analysis and drug discovery workflows, offering CIOs a blueprint for enterprise-scale AI transformation in regulated industries.